Importer of Controlled Substances Application: AMRI Rensselaer, Inc., 15176 [2018-07165]
Download as PDF
<![CDATA[
15176
Federal Register / Vol. 83, No. 68 / Monday, April 9, 2018 / Notices
Controlled substance
Drug code
Dihydrocodeine ................................................................................................................................................................
Diphenoxylate ..................................................................................................................................................................
Levomethorphan ..............................................................................................................................................................
Levorphanol .....................................................................................................................................................................
Meperidine .......................................................................................................................................................................
Dextropropoxyphene, bulk (non-dosage forms) ..............................................................................................................
Thebaine ..........................................................................................................................................................................
Noroxymorphone .............................................................................................................................................................
Alfentanil ..........................................................................................................................................................................
Sufentanil .........................................................................................................................................................................
The company plans to import the bulk
controlled substances for distribution of
analytical reference standards to its
customers for research and analytical
purposes.
Dated: April 2, 2018.
Susan A. Gibson,
Deputy Assistant Administrator.
[FR Doc. 2018–07167 Filed 4–6–18; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: AMRI Rensselaer, Inc.
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
DATES:
or before May 9, 2018. Such persons
may also file a written request for a
hearing on the application on or before
May 9, 2018.
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All request for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/LJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DRW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
Comments and requests for hearings on
applications to import narcotic raw
material are not appropriate. 72 FR 3417
(January 25, 2007).
ADDRESSES:
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
delegated to the Assistant Administrator
of the DEA Diversion Control Division
(‘‘Assistant Administrator’’) pursuant to
section 7 of 28 CFR part 0, appendix to
subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on March
21, 2018, AMRI Rensselaer, 33 Riverside
Ave., Rensselaer, NY 12144, applied to
be registered as an importer of the
following basic class of controlled
substance:
Drug code
Poppy Straw Concentrate ...............................................................................................................................................
Dated: April 2, 2018.
Susan A. Gibson,
Deputy Assistant Administrator.
[FR Doc. 2018–07165 Filed 4–6–18; 8:45 am]
sradovich on DSK3GMQ082PROD with NOTICES
BILLING CODE 4410–09–P
NATIONAL FOUNDATION ON THE
ARTS AND THE HUMANITIES
Arts Advisory Panel Meetings
National Endowment for the
Arts, National Foundation on the Arts
and Humanities.
VerDate Sep<11>2014
18:06 Apr 06, 2018
Jkt 244001
Notice of meetings.
Pursuant to the Federal
Advisory Committee Act, as amended,
notice is hereby given that 2 meetings of
the Arts Advisory Panel to the National
Council on the Arts will be held by
teleconference unless otherwise noted.
DATES: See the SUPPLEMENTARY
INFORMATION section for individual
meeting times and dates. All meetings
are Eastern time and ending times are
approximate:
SUMMARY:
National Endowment for the
Arts, Constitution Center, 400 7th St.
SW, Washington, DC 20506.
FOR FURTHER INFORMATION CONTACT:
Further information with reference to
these meetings can be obtained from Ms.
Sherry P. Hale, Office of Guidelines &
Panel Operations, National Endowment
ADDRESSES:
National Endowment for the Arts
AGENCY:
ACTION:
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
II
II
II
II
II
II
II
II
II
II
SUPPLEMENTARY INFORMATION:
Controlled substance
The company plans to import the
listed controlled substance to
manufacture bulk controlled substance
for distribution to its customers.
9120
9170
9210
9220
9230
9273
9333
9668
9737
9740
Schedule
9670
Schedule
II
for the Arts, Washington, DC 20506;
hales@arts.gov, or call 202/682–5696.
The
closed portions of meetings are for the
purpose of Panel review, discussion,
evaluation, and recommendations on
financial assistance under the National
Foundation on the Arts and the
Humanities Act of 1965, as amended,
including information given in
confidence to the agency. In accordance
with the determination of the Chairman
of July 5, 2016, these sessions will be
closed to the public pursuant to
subsection (c)(6) of section 552b of title
5, United States Code.
The upcoming meetings are:
Literature Fellowships: Translation
Projects (review of applications): This
meeting will be closed. Date and time:
May 16, 2018; 3:00 p.m. to 5:00 p.m.
SUPPLEMENTARY INFORMATION:
E:\FR\FM\09APN1.SGM
09APN1
]]>Agencies
[Federal Register Volume 83, Number 68 (Monday, April 9, 2018)]
[Notices]
[Page 15176]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-07165]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Importer of Controlled Substances Application: AMRI Rensselaer,
Inc.
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before May 9, 2018. Such
persons may also file a written request for a hearing on the
application on or before May 9, 2018.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DRW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
request for hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/LJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DRW, 8701 Morrissette Drive,
Springfield, Virginia 22152. Comments and requests for hearings on
applications to import narcotic raw material are not appropriate. 72 FR
3417 (January 25, 2007).
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been delegated
to the Assistant Administrator of the DEA Diversion Control Division
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0,
appendix to subpart R.
In accordance with 21 CFR 1301.34(a), this is notice that on March
21, 2018, AMRI Rensselaer, 33 Riverside Ave., Rensselaer, NY 12144,
applied to be registered as an importer of the following basic class of
controlled substance:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Poppy Straw Concentrate.................. 9670 II
------------------------------------------------------------------------
The company plans to import the listed controlled substance to
manufacture bulk controlled substance for distribution to its
customers.
Dated: April 2, 2018.
Susan A. Gibson,
Deputy Assistant Administrator.
[FR Doc. 2018-07165 Filed 4-6-18; 8:45 am]
BILLING CODE 4410-09-P
